Question: are astrazeneca shares worth buying?
Answer: Valuation metrics show that AstraZeneca PLC may be undervalued. Its Value Score of B indicates it would be a good pick for value investors. The financial health and growth prospects of AZN, demonstrate its potential to perform inline with the market. It currently has a Growth Score of C.